- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||emapalumab|
|Search PubMed titles||emapalumab|
|Search PubMed titles/abstracts||emapalumab|
|Emapalumab (NI-0501) is an investigational, fully human monoclonal antibody targeting interferon gamma (IFNγ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2006109191, and in which NI-0501 is confirmed as an exemplary antibody .